LYTIR

Insider · SEC Form 4 · President & CEO

ROBIN HOWARD W

In the 12 months to Nov 8, 2026, on the open market: sold $1.2M of NKTR. Filed a median of 2 business days after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $1.2M in total.Jun: Insider sales $1.2MAug: Insider sales $30KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $1.2M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. NKTRSold: NEKTAR THERAPEUTICS Aug 18, 2026 418 shares filed Aug 20, 2026 54,627 shares held directly after, as filed filing $30K
  2. NKTRSold: NEKTAR THERAPEUTICS Jun 17, 2026 10,000 shares filed Jun 18, 2026 2 transactions 10b5-1 plan filing $612K
  3. NKTRSold: NEKTAR THERAPEUTICS Jun 16, 2026 10,000 shares filed Jun 18, 2026 2 transactions 10b5-1 plan filing $603K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.